Impact Biomedical Ratios (2022-2026) | IBO

Ratios Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) -57.14%94.44%
EBT Margin (Quarter) -1,598.00%-205,028.57%-8,194.44%-32,628.57%
EBIT Margin (Quarter) -1,500.00%-16,471.43%-5,266.67%-32,700.00%
EBITDA Margin (Quarter) -1,500.00%-16,471.43%-5,266.67%-32,700.00%
Operating Margin (Quarter) -1,500.00%-16,471.43%-5,266.67%-32,700.00%
Net Margin (Quarter) -1,464.00%-205,028.57%-8,194.44%-32,628.57%
FCF Margin (Quarter) -9,914.29%-3,405.56%-6,628.57%
Efficiency
Inventory Average (Quarter) 0.49M0.49M0.27M0.06M
Assets Average (Quarter) 45.54M44.86M44.49M44.24M45.41M33.49M20.17M19.56M18.63M17.81M17.25M
Asset Utilization Ratio (Quarter) 0.000.000.00
Leverage & Solvency
Interest Coverage Ratio (Quarter) -5.40-9.66-10.42-7.95-0.91-0.97-9.11-0.69-0.56-1.01-97.15-0.79-0.90-0.84-0.21
Debt Ratio (Quarter) 0.270.170.440.461.171.26
Times Interest Earned (Quarter) -5.40-9.66-10.42-7.95-0.91-0.97-9.11-0.69-0.56-1.01-97.15-0.79-0.90-0.84-0.21
Valuation
Enterprise Value (Quarter) 3.11M3.08M3.06M3.04M3.00M3.01M3.00M0.98M1.65M2.96M2.96M3.24M3.23M
Return Ratios
Return on Sales (Quarter) -0.16%-20.50%-0.82%-3.26%
Return on Capital Employed (Quarter) -11.79%-12.70%-13.04%-12.15%-8.27%-121.29%-284.32%816.29%568.75%-34.71%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.02%-0.02%-0.01%-0.01%